episil® oral mucositis pain management episil® is an effective, safe and convenient new pain treatment for patients suffering from oral mucositis. The product is granted FDA 510(k) market clearance in the US and CE mark in EU. episil® is being launched globally by Camurus and its partners. Read more »
FluidCrystal® Injection depot Compatibility with prefilled syringes and autoinjectors, tuneable release profiles, and simple manufacturing, makes the FluidCrystal® injection depot stand out as a leading technology for daily, weekly, or monthly extended release products.
Meet Camurus at JP Morgan Camurus is attending the annual JP Morgan meeting in San Francisco, January 13-16, 2014. If you plan to go there, please take the opportunity to meet with the Camurus team. Read more »
Camurus receives option-exercise milestone for octreotide FluidCrystal® product CAM2029